PathoVax is a biotech start-up from Johns Hopkins commercializing RGVax.
Aardvark Therapeutics
1 follower
Hightower Clinical
1 follower
Solace
2 followers
Transcure
2 followers
Merck
349 followers
Worldwide Clinical Trials
19 followers
American Academy of Family Physicians
1 follower
Unwell
1 follower
Latigo Biotherapeutics
1 follower
Karoo Health
1 follower
Yale New Haven Health System
3 followers
Revvity
15 followers